ReviewWorld journal of gastrointestinal endoscopy2021
Six intragastric balloons: Which to choose?
Review in World journal of gastrointestinal endoscopy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- Early Termination of a First-in-Human Trial of a Swallowable Self-Expanding Intragastric Balloon (IGBalloon©) Due to Small Bowel Obstruction.Obesity surgery · 2026Trial
- Endoscopic Bariatric Therapies in Inflammatory Bowel Disease: Patient Selection, Nutritional Risk, and Periprocedural Management.Metabolites · 2026Review
- Short-Term Safety and Healthcare Utilization Following Intragastric Balloon Placement in Patients With and Without Diabetes Mellitus: A Propensity-Matched Analysis.Obesity surgery · 2026Article
- Advances and future directions in endoscopic bariatric therapies.World journal of gastrointestinal endoscopy · 2025Review
- Multicenter Retrospective Analysis of Consecutive Swallowable Gastric Balloon Treatments in a Community Obesity Care Setting.Obesity surgery · 2025Article
- Endoscopic management of intragastric balloon related gastric outlet obstruction: A case report and review of literature.World journal of clinical cases · 2025Article
- Weight Loss Maintenance 1 Year after the Swallowable Gastric Balloon: Results from an International Multicenter Study.Obesity surgery · 2025Article
- Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease.World journal of gastroenterology · 2025Article
- Review
- The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity.Diabetes, obesity & metabolism · 2025Review
- A single-center experience of safety and effectiveness of adjustable intragastric balloon in patients with super obesity.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2025Article
- Intragastric balloon for obesity treatment: Systematic review and meta-analysis of randomized controlled trials.Endoscopy international open · 2025Review
- The evolution and current state of bariatric endoscopy in Western countries.Clinical endoscopy · 2024Review
- A safe method for rapid therapeutic pancreatic cooling.iScience · 2024Article
- Intragastric Balloon as a First Step Before Metabolic Bariatric Surgery in Patients with BMI ≥ 50 kg/mObesity surgery · 2024Article
- "Evaluating the Safety of the Intragastric Balloon".Obesity surgery · 2024Article
- Spontaneous Intragastric Balloon Hyperinflation: Two Cases and Outcomes.Obesity surgery · 2024Article
- Impact of a Health Coach-Led, Text-Based Digital Behavior Change Intervention on Weight Loss and Psychological Well-Being in Patients Receiving a Procedureless Intragastric Balloon Program: Prospective Single-Arm Study.JMIR formative research · 2024Article
- Evaluating Weight Loss Efficacy in Obesity Treatment with Allurion's Ingestible Gastric Balloon: A Retrospective Study Utilizing the Scale App Health Tracker.Clinics and practice · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endoscopically placed intragastric balloons (IGBs) have played a significant role in obesity treatment over the last 30 years, successfully bridging the gap between lifestyle modification/pharmacotherapy and bariatric surgery. Since they provide a continuous sensation of satiety that helps the ingestion of smaller portions of food, facilitating maintenance of a low-calorie diet, they have generally been considered an effective and reversible, less invasive, non-surgical procedure for weight loss. However, some studies indicate that balloons have limited sustainable effectiveness for the vast majority attempting such therapy, resulting in a return to the previous weight after balloon removal. In this review we try to summarize the pros and cons of various balloon types, to guide decision making for both the physician and the obese individual looking for effective treatment. We analyzed the six most commonly used IGBs, namely the liquid-filled balloons Orbera, Spatz3, ReShape Duo and Elipse, and the gas-filled Heliosphere and Obalon - also including comments on the adjustable Spatz3, and the swallowable Obalon and Elipse - to optimize the choice for maximum efficacy and safety.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.